A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases.
J Crohns Colitis
; 17(6): 896-908, 2023 Jun 16.
Article
in En
| MEDLINE
| ID: mdl-36661279
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Inflammatory Bowel Diseases
Type of study:
Prognostic_studies
Limits:
Child
/
Humans
Language:
En
Journal:
J Crohns Colitis
Journal subject:
GASTROENTEROLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Belgium
Country of publication:
United kingdom